MedPath

PMS-FLUTICASONE PROPIONATE/SALMETEROL DPI

PMS-FLUTICASONE PROPIONATE/SALMETEROL DPI

Approved
DIN Number

02494515

Drug Class

Human

Market Date

Mar 5, 2020

Company
HC

Pharmascience Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02494515
AIG Number0238341002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
R03AK06 SALMETEROL AND FLUTICASONE
Product Specifications
Dosage FormPowder
Route of AdministrationInhalation
AHFS Classification68:04.00
Health Canada Classification

ACTIVE INGREDIENTS (2)

FLUTICASONE PROPIONATEActive
Strength: 250 MCG / ACT
Monograph: FLUTICASONE PROPIONATE
SALMETEROL (SALMETEROL XINAFOATE)Active
Strength: 50 MCG / ACT
Monograph: SALMETEROL (SALMETEROL XINAFOATE)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.